Monitoring glucose levels in women after gestational diabetes
Official title: Early Investigation of Glucose Monitoring After Gestational Diabetes (ENGAGED): Utility and Acceptability of Continuous Glucose Monitoring in the Early Postpartum Period After Gestational Diabetes Mellitus
Run by Ohio State University · NCT06184373 · Data updated 2026-11-12
This study is testing if wearing a continuous glucose monitor can help women who had gestational diabetes keep track of their blood sugar levels after giving birth.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | June 6, 2025 |
| Main results expected | May 30, 2027 |
| Study ends | May 30, 2027 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT06184373 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are postpartum women who have had a recent pregnancy affected by gestational diabetes.
✕Probably not a fit
Patients with pregestational diabetes or those using diabetes medications immediately after delivery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the use of continuous glucose monitors (CGM) in postpartum women who have experienced gestational diabetes (GDM). Participants will wear a CGM device at 6-8 weeks postpartum to track their glucose levels and will complete surveys regarding their quality of life during this period. The goal is to assess the acceptability and feasibility of CGM as a screening tool for ongoing dysglycemia in women with a history of GDM, as traditional follow-up methods have low adherence rates. Data collected may inform future studies on the effectiveness of CGM in this population.
Why it matters
Potential benefit: If successful, this approach could improve postpartum glucose monitoring and follow-up care for women with a history of gestational diabetes.
How similar studies have gone: While the use of CGM in gestational diabetes is not extensively studied, similar approaches in diabetes management have shown promise, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women with a viable singleton intrauterine pregnancy * Able to understand the study, and having understood, provide written informed consent in English * Recent pregnancy affected by gestational diabetes Exclusion Criteria: * Pregestational Diabetes (Type I or Type II) * Continued use of diabetes medications (including metformin and insulin) immediately after delivery * Preterm delivery (\< 37 weeks gestation) * Twin or higher order gestation * No access to a smartphone * Unable or unwilling to wear CGM or return for follow up at postpartum mother-infant dyad clinic * Participation in this trial in a prior pregnancy * History of skin allergy to adhesive products or CGM
Where it's running
-
Ohio State University Medical Center
Columbus, Ohio, United States Recruiting
Study contacts
- Study coordinator: Rachel Gordon, MD, MPH
- Email: rachel.gordon@osumc.edu
- Phone: 614-293-7980
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Maltodextrin vs Sugar Water for Pre-Surgery Carbohydrate Loading in Older Adults
This study tests whether a maltodextrin drink before surgery leaves less fluid in the stomach than sugar water for adults 60 and older undergoing leg surgery with spinal or epidural anesthesia.
-
Managing pasireotide-related high blood sugar in acromegaly with a ketogenic diet
This study tests whether a very-low carbohydrate ketogenic diet can help lower HbA1c and fasting glucose in adults with acromegaly who develop high blood sugar while taking pasireotide.
-
Risk-stratified management of inavolisib-induced hyperglycemia in breast cancer patients
This observational study tests whether using a pre-treatment risk-stratified plan to manage high blood sugar from inavolisib helps patients stay on therapy.
-
Early Glucose Patterns in Pregnant Women at Risk for GDM
This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Personality Traits and Biochemical Risk Markers in Routine Health Assessments
This study tests whether personality traits relate to the number of abnormal lab results found during a standard health checkup in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.